AtriCure (ATRC) Tops Q2 EPS by 37c
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $44.30 +1.86%
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Basic and diluted net loss per share: -0.21
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
AtriCure (NASDAQ: ATRC) reported Q2 EPS of ($0.20), $0.37 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $40.8 million versus the consensus estimate of $35.95 million.
2020 Financial Guidance
As previously reported, AtriCure is not providing 2020 financial guidance due to the continued uncertainties from the impact of COVID-19.
For earnings history and earnings-related data on AtriCure (ATRC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
- Algorhythm Holdings (RIME) Tops Q2 EPS by 54c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
